Search Results - Kantarjian, Hagop M.

PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): ph... by Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, Hagop M., Gómez Almaguer, David, Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J. M.

Get full text

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers by Van Roosbroeck, Katrien, Fanini, Francesca, Setoyama, Tetsuro, Ivan, Cristina, Rodríguez Aguayo, Cristian, Fuentes Mattei, Enrique, Xiao, Lianchun, Vannini, Ivan, Redis, Roxana S., D'Abundo, Lucilla, Zhang, Xinna, Nicoloso, Milena S., Rossi, Simona, González Villasana, Vianey, Rupaimoole, Rajesha, Ferracin, Manuela, Morabito, Fortunato, Neri, Antonino, Ruvolo, Peter P., Ruvolo, Vivian R., Pecot, Chad V., Amadori, Dino, Abruzzo, Lynne V., Calin, Steliana, Wang, Xuemei, You, M. James, Ferrajoli, Alessandra, Orlowski, Robert, Plunkett, William, Lichtenberg, Tara M., Davuluri, Ramana V., Berindan Neagoe, Ioana, Negrini, Massimo, Wistuba, Ignacio I., Kantarjian, Hagop M., Sood, Anil K., Lopez Berestein, Gabriel, Keating, Michael J., Fabbri, L. Muller, Calin, George A.

Get full text